查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827718

2025年C反應蛋白檢測全球市場報告

C-Reactive Protein Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，C反應蛋白檢測市場規模穩定成長，從2024年的34.5億美元增加到2025年的35.2億美元，複合年成長率為2.0%。預測期內的成長歸因於發炎性疾病盛行率的上升、心血管風險評估、人口老化、醫療基礎設施的完善以及醫療篩檢計畫的推進。

預計未來幾年C反應蛋白檢測市場規模將穩定成長，到2029年將達到42.8億美元，複合年成長率為5.0%。預測期內的成長可歸因於肥胖率上升、個人化醫療和生物標記、遠端醫療和遠端監控、早期疾病檢測以及生活方式相關的發炎。預測期內的主要趨勢包括診斷檢測、穿戴式健康技術、技術解決方案、策略聯盟以及工業4.0的採用。

C反應蛋白 (CRP) 檢測是一種診斷程序，用於評估血液中 CRP 的水平。 CRP 是肝臟在發炎反應中產生的蛋白質。當身體受到損傷或感染疾病時，會產生發炎作為防禦機制。 CRP 檢測主要用於識別感染疾病引起的發炎。

CRP檢測市場主要使用的檢測法包括酵素結合免疫吸附檢測法（ELISA）、化學冷光免疫檢測（CLIA）和免疫比濁檢測法。例如，ELISA是一種定量測量血清中人體CRP濃度的技術，有助於監測風濕熱和發炎等病症。 ELISA是一種專注於測量抗體、抗原、蛋白質和糖蛋白的生物檢測法。 CRP檢測有助於診斷和監測各種疾病，包括糖尿病、類風濕性關節炎、心血管疾病、發炎性腸道疾病和癌症，廣泛應用於臨床、醫院和診斷實驗室。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供 C 反應蛋白檢測市場統計數據，例如全球 C 反應蛋白檢測行業規模、各地區佔有率、競爭對手的市場佔有率、詳細的 C 反應蛋白檢測細分市場、市場趨勢和機遇，以及您在 C 反應蛋白檢測行業取得成功所需的數據。本 C 反應蛋白檢測市場研究報告對該行業的現狀和未來情況進行了詳細分析，為您提供所需的一切觀點。

未來五年5.0%的預測成長率較我們先前對該市場的預測略有下降，下降了0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自日本和法國等主要地區的乳膠增強免疫檢測試劑和發炎標記自動分析儀徵收關稅直接影響美國，從而導致感染監測能力下降和心血管風險評估成本上升。由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，這種影響也可能更為廣泛。

心血管疾病 (CVD) 盛行率的不斷上升預計將推動 C 反應蛋白檢測市場的成長。心血管疾病包括血管病變、結構性問題、血栓等心臟疾病。雖然 CVD 的確切病因尚不完全清楚，但有幾個因素可能會增加患病風險。其中一個關鍵因素是由於不良飲食、缺乏運動、吸煙和飲酒導致的行為風險，這些風險會導致動脈中脂肪沉積（動脈粥狀硬化），並增加血栓的風險。這些行為風險會導致血壓升高、血糖升高、血脂升高、體重增加和肥胖。 CVD 盛行率的不斷上升推動了對 C 反應蛋白檢測的需求，這種檢測與膽固醇檢測一樣，可以診斷或預測心血管疾病的可能性。例如，衛生指標與評估研究所於2023年12月報告稱，2022年全球心血管疾病死亡人數將達到1,980萬，而缺血性心臟疾病的死亡率為每10萬人108.8人。高收縮壓是心血管疾病相關傷殘調整生命年（DALY）的主要因素，而飲食風險和空氣污染已成為加劇此全球問題的重要行為和環境因素。

臨床試驗的成長預計將進一步推動C反應蛋白檢測市場的發展。臨床試驗在評估醫療干預措施（包括C反應蛋白檢測等診斷程序）的安全性、有效性和潛在益處方面發揮著至關重要的作用。這些臨床試驗有助於評估C反應蛋白檢測在診斷心血管疾病和預測心臟相關疾病風險的準確性和有效性。截至2023年5月，ClinicalTrials.gov已註冊452,604項臨床試驗，其中64,838項正在積極尋找參與者。臨床試驗的成長證實了C反應蛋白檢測日益成長的重要性，並有助於市場擴張。

C反應蛋白檢測市場的一個顯著趨勢是測量設備的技術進步。市場主要企業正優先考慮技術創新，以鞏固其市場地位。這些公司正在將下一代C反應蛋白檢測技術融入其檢測方法中，提供具有最大輸出和多種應用等優勢的先進解決方案。例如，總部位於芬蘭的診斷檢測解決方案公司Aidian於2022年2月推出了QuikRead go wrCRP & wrCRP+Hb套件。該套件可在一次運行中從單一檢體中提供兩種結果—寬範圍CRP和Hb。寬範圍CRP檢測可實現CRP測量，有助於評估新生兒敗血症等疾病、預測慢性阻塞性肺病（COPD）的病情嚴重程度以及評估心血管風險。這項技術進步體現了該公司致力於提供高效、全面的C反應蛋白檢測解決方案的承諾。

為了提升市場地位和盈利，C反應蛋白檢測市場的主要企業正優先考慮技術創新，推出新的技術療法，例如C反應蛋白抗原檢測。 C反應蛋白（CRP）抗原檢測是一種血液檢測，旨在測量人體C反應蛋白的水平，C反應蛋白是肝臟對發炎反應所產生的蛋白質。印度醫療技術公司LumiraDx Healthcare Pvt Ltd.於2022年11月推出了C反應蛋白抗原檢測。這種微流體免疫測量提供了一種快速且便捷的全血CRP水平測量方法，並描述了一種可供患者附近的醫療保健專業人員使用的自動化體外診斷測試。

2022年6月，美國製藥生技公司輝瑞以5.25億美元收購了ReViral Ltd.。此次收購增強了輝瑞的感染疾病物組合，並強化了其開發抗呼吸道融合細胞病毒（RSV）藥物和疫苗的決心。 ReViral Ltd.是一家總部位於英國的生物技術公司，專注於病毒性疾病的創新療法和CRP檢測。

C反應蛋白檢測市場的主要企業包括賽默飛世爾科技公司、F Hoffmann-La Roche AG、丹納赫公司、Quest Diagnostics Incorporated、西門子股份公司、雅培實驗室、Aidian Oy、Boditech Med Inc.、堀場製作公司有限公司、Laboratory Corporation、默克公司、Pwan、Sotoin、Soin​​kkone. Biotechs O​​kkkk、B.k. Scientific SE、Inova Diagnostics Inc.、Luminex Corporation、Sekisui Diagnostics LLC、Sysmex Corporation、Tosoh Corporation、Trinity Biotech Plc、WerfenLife Group LLC、ZEUS Scientific Inc.、BioMerieux SA、Biomerica Inc.、Gold Standard Diagnostics Corp.、ImmmedNnoscence Corp.、HadovaNaknos。

2024年，北美是C反應蛋白檢測市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。 C反應蛋白檢測市場報告涵蓋以下地區：亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

C反應蛋白檢測市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

C反應蛋白檢測市場涵蓋營業單位透過儀器和試劑產生的收益。市場規模包括服務供應商銷售或包含在其服務產品中的相關商品的價值。僅包括營業單位之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球C反應蛋白檢測：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球C反應蛋白檢測市場：成長率分析
  • 全球C反應蛋白檢測市場表現：規模與成長，2019-2024年
  • 全球C反應蛋白檢測市場預測：規模與成長，2024-2029年，2034年
  • 全球 C 反應蛋白檢測：總潛在市場 (TAM)

第6章 市場細分

  • 全球C反應蛋白檢測市場（依檢測類型、效能和預測），2019-2024年，2024-2029年，2034年
  • 酵素免疫分析法（ELISA）
  • 化學冷光免疫檢測（CLIA）
  • 免疫比濁法
  • 全球C反應蛋白檢測市場的應用、效能與預測，2019-2024年、2024-2029年、2034年
  • 糖尿病
  • 類風濕性關節炎
  • 心血管疾病
  • 發炎性腸道疾病
  • 癌症
  • 其他
  • 全球C反應蛋白檢測市場最終用途、績效及預測（2019-2024年、2024-2029年、2034年）
  • 診所
  • 醫院
  • 診斷實驗室
  • 全球 C 反應蛋白檢測市場：酵素免疫分析法試驗 (ELISA) 細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 直接ELISA
  • 間接ELISA
  • 夾心ELISA
  • 全球 C 反應蛋白檢測市場：化學冷光免疫檢測(CLIA) 細分、按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 基於光度計的化學發光免疫分析
  • 自動化化學發光免疫分析系統
  • 全球 C 反應蛋白檢測市場：免疫檢測法細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 免疫比濁檢測法
  • 乳膠凝集免疫比濁法

第7章 區域和國家分析

  • 全球C反應蛋白檢測市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球C反應蛋白檢測市場（依國家、績效及預測）2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • C反應蛋白檢測市場：競爭格局
  • C反應蛋白檢測市場：公司簡介
    • Thermo Fisher Scientific Inc.
    • F Hoffmann-La Roche AG
    • Danaher Corporation
    • Quest Diagnostics Incorporated
    • Siemens AG

第31章：其他領先和創新企業

  • Abbott Laboratories
  • Aidian Oy
  • Boditech Med Inc.
  • Horiba Ltd.
  • Laboratory Corporation
  • Merck KGAA
  • Randox Laboratories Limited
  • Getein BIoTech Inc.
  • Bio-Rad Laboratories Inc.
  • DiaSorin SpA
  • Eurofins Scientific SE
  • Inova Diagnostics Inc.
  • Luminex Corporation
  • Sekisui Diagnostics LLC
  • Sysmex Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年C反應蛋白檢測市場：提供新機會的國家
  • 2029年C反應蛋白檢測市場：細分市場帶來新機會
  • C反應蛋白檢測市場2029年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r21315u

C-reactive protein (CRP) testing is a diagnostic procedure that assesses the concentration of CRP in the bloodstream, a protein produced by the liver in response to inflammation. In cases of injury or infection, the body initiates inflammation as a protective mechanism. CRP testing is primarily employed to identify inflammation resulting from infections.

The primary assay methods utilized in the CRP testing market include enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and immunoturbidimetric assays. ELISA, for instance, is a technique employed to quantitatively measure human CRP levels in serum, aiding in the monitoring of conditions such as rheumatic fever and inflammatory processes. ELISA serves as a biological assay focusing on the measurement of antibodies, antigens, proteins, and glycoproteins. CRP testing is widely applied in clinical settings, hospitals, and diagnostic laboratories, contributing to the diagnosis and monitoring of various conditions such as diabetes, rheumatoid arthritis, cardiovascular diseases, inflammatory bowel disease, cancer, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The c-reactive protein testing market research report is one of a series of new reports from The Business Research Company that provides c-reactive protein testing market statistics, including c-reactive protein testing industry global market size, regional shares, competitors with an c-reactive protein testing market share, detailed c-reactive protein testing market segments, market trends and opportunities, and any further data you may need to thrive in the c-reactive protein testing industry. This c-reactive protein testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The c-reactive protein testing market size has grown steadily in recent years. It will grow from $3.45 billion in 2024 to $3.52 billion in 2025 at a compound annual growth rate (CAGR) of 2.0%. The growth in the historic period can be attributed to increased inflammatory disease prevalence, cardiovascular risk assessment, increased aging population, increased healthcare infrastructure, and healthcare screening programs.

The c-reactive protein testing market size is expected to see steady growth in the next few years. It will grow to $4.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to rising obesity rates, personalized medicine and biomarkers, telehealth and remote monitoring, early disease detection, and lifestyle-related inflammation. Major trends in the forecast period include diagnostic testing advancements, wearable health technology, technological solutions, strategic collaborations, and industry 4.0 introduction.

The forecast of 5.0% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on latex-enhanced immunoassay reagents and automated inflammation marker analyzers, sourced from key regions such as Japan and France, which could lead to reduced capacity for infection monitoring and higher costs for cardiovascular risk assessment.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rise in cardiovascular disease (CVD) cases is expected to drive the growth of the C-reactive protein testing market. Cardiovascular diseases encompass heart conditions such as diseased vessels, structural issues, and blood clots. While the exact cause of CVD is not fully understood, several factors can increase the risk of developing it. One significant factor is behavioral risk, stemming from poor diet, insufficient physical activity, smoking, and alcohol consumption, which leads to the buildup of fatty deposits in the arteries (atherosclerosis) and heightens the risk of blood clots. These behavioral risks contribute to elevated blood pressure, glucose levels, blood lipids, weight gain, and obesity. As CVD cases rise, there is an increasing demand for C-reactive protein testing to diagnose or predict the likelihood of cardiovascular issues, similar to cholesterol testing. For example, in December 2023, the Institute for Health Metrics and Evaluation reported that global deaths from cardiovascular diseases reached 19.8 million in 2022, with ischemic heart disease accounting for 108.8 deaths per 100,000 people. High systolic blood pressure was the leading contributor to disability-adjusted life years (DALYs) associated with CVD, while dietary risks and air pollution emerged as significant behavioral and environmental factors exacerbating this global issue.

The increasing number of clinical trials is anticipated to further boost the c-reactive protein testing market. Clinical trials play a crucial role in assessing the safety, efficacy, and potential benefits of medical interventions, including diagnostic procedures like c-reactive protein testing. These trials are instrumental in evaluating the accuracy and efficacy of CRP testing in diagnosing cardiovascular diseases and predicting the risk of heart-related conditions. As of May 2023, there are 452,604 clinical studies registered on ClinicalTrials.gov, with 64,838 actively seeking participants, marking a notable increase from early 2021. This rise in clinical trials underscores the growing importance of c-reactive protein testing, contributing to the market's expansion.

A noteworthy trend in the c-reactive protein testing market is the technological advancement in measuring devices. Key players in the market are prioritizing technological innovation to strengthen their market positions. These companies are integrating next-generation c-reactive testing technologies into their methods, providing advanced solutions with benefits like maximum output and multiple usages. For example, Aidian, a Finnish-based diagnostic tests and solutions company, introduced the QuikRead go wrCRP & wrCRP+Hb kits in February 2022. This kit delivers two results, a wide range of CRP and Hb, from a single sample with one analysis. The wide-range CRP test allows for CRP readings that assess conditions like neonatal sepsis, predict disease severity in COPD, and aid in cardiovascular risk assessment. This technological advancement reflects a commitment to offering efficient and comprehensive c-reactive protein testing solutions.

Key players in the c-reactive protein testing market are prioritizing innovation by introducing new technological treatments, such as the C-Reactive Protein antigen test, to enhance their market standing and profitability. The C-Reactive Protein (CRP) antigen test is a blood test designed to measure the body's level of C-Reactive Protein, a protein produced by the liver in response to inflammation. LumiraDx Healthcare Pvt Ltd., an India-based medical technology company, launched the C-Reactive Protein antigen test in November 2022. This microfluidic immunoassay offers a quick and simple way to measure CRP levels in whole blood, providing an automated in vitro diagnostic test for healthcare professionals to use in close proximity to patients.

In June 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology company, acquired ReViral Ltd. for $525 million. This acquisition enhances Pfizer's anti-infective portfolio and reinforces its commitment to developing medicines and vaccines to combat respiratory syncytial virus (RSV). ReViral Ltd. is a UK-based biotech company that specializes in innovative therapies for viral diseases and C-reactive protein (CRP) testing.

Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMerieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the c-reactive protein testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The c-reactive protein testing market includes revenues earned by entities by devices and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

C-Reactive Protein Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on c-reactive protein testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for c-reactive protein testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The c-reactive protein testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA); Chemiluminescence Immunoassay (CLIA); Immunoturbidimetric Assays
  • 2) By Application: Diabetes; Rheumatoid Arthritis; Cardiovascular Disease; Inflammatory Bowel Disease; Cancer; Other Applications
  • 3) By End Use: Clinics; Hospitals; Diagnostic Laboratories
  • Subsegments:
  • 1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA; Indirect ELISA; Sandwich ELISA
  • 2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA; Automated CLIA Systems
  • 3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays; Latex Agglutination Immunoturbidimetric Assays
  • Companies Mentioned: Thermo Fisher Scientific Inc.; F Hoffmann-La Roche AG; Danaher Corporation; Quest Diagnostics Incorporated; Siemens AG; Abbott Laboratories; Aidian Oy; Boditech Med Inc.; Horiba Ltd.; Laboratory Corporation; Merck KGAA; Randox Laboratories Limited; Getein Biotech Inc.; Bio-Rad Laboratories Inc.; DiaSorin S.p.A.; Eurofins Scientific SE; Inova Diagnostics Inc.; Luminex Corporation; Sekisui Diagnostics LLC; Sysmex Corporation; Tosoh Corporation; Trinity Biotech Plc; WerfenLife Group LLC; ZEUS Scientific Inc.; BioMerieux SA; Biomerica Inc.; Gold Standard Diagnostics Corp.; Immunodiagnostic Systems Holdings PLC; Nova Biomedical Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. C-Reactive Protein Testing Market Characteristics

3. C-Reactive Protein Testing Market Trends And Strategies

4. C-Reactive Protein Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global C-Reactive Protein Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global C-Reactive Protein Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global C-Reactive Protein Testing Market Growth Rate Analysis
  • 5.4. Global C-Reactive Protein Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global C-Reactive Protein Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global C-Reactive Protein Testing Total Addressable Market (TAM)

6. C-Reactive Protein Testing Market Segmentation

  • 6.1. Global C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Chemiluminescence Immunoassay (CLIA)
  • Immunoturbidimetric Assays
  • 6.2. Global C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diabetes
  • Rheumatoid Arthritis
  • Cardiovascular Disease
  • Inflammatory Bowel Disease
  • Cancer
  • Other Applications
  • 6.3. Global C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinics
  • Hospitals
  • Diagnostic Laboratories
  • 6.4. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct ELISA
  • Indirect ELISA
  • Sandwich ELISA
  • 6.5. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Chemiluminescence Immunoassay (CLIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Luminometer-Based CLIA
  • Automated CLIA Systems
  • 6.6. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Immunoturbidimetric Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nephelometry-Based Immunoturbidimetric Assays
  • Latex Agglutination Immunoturbidimetric Assays

7. C-Reactive Protein Testing Market Regional And Country Analysis

  • 7.1. Global C-Reactive Protein Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global C-Reactive Protein Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific C-Reactive Protein Testing Market

  • 8.1. Asia-Pacific C-Reactive Protein Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China C-Reactive Protein Testing Market

  • 9.1. China C-Reactive Protein Testing Market Overview
  • 9.2. China C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India C-Reactive Protein Testing Market

  • 10.1. India C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan C-Reactive Protein Testing Market

  • 11.1. Japan C-Reactive Protein Testing Market Overview
  • 11.2. Japan C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia C-Reactive Protein Testing Market

  • 12.1. Australia C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia C-Reactive Protein Testing Market

  • 13.1. Indonesia C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea C-Reactive Protein Testing Market

  • 14.1. South Korea C-Reactive Protein Testing Market Overview
  • 14.2. South Korea C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe C-Reactive Protein Testing Market

  • 15.1. Western Europe C-Reactive Protein Testing Market Overview
  • 15.2. Western Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK C-Reactive Protein Testing Market

  • 16.1. UK C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany C-Reactive Protein Testing Market

  • 17.1. Germany C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France C-Reactive Protein Testing Market

  • 18.1. France C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy C-Reactive Protein Testing Market

  • 19.1. Italy C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain C-Reactive Protein Testing Market

  • 20.1. Spain C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe C-Reactive Protein Testing Market

  • 21.1. Eastern Europe C-Reactive Protein Testing Market Overview
  • 21.2. Eastern Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia C-Reactive Protein Testing Market

  • 22.1. Russia C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America C-Reactive Protein Testing Market

  • 23.1. North America C-Reactive Protein Testing Market Overview
  • 23.2. North America C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA C-Reactive Protein Testing Market

  • 24.1. USA C-Reactive Protein Testing Market Overview
  • 24.2. USA C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada C-Reactive Protein Testing Market

  • 25.1. Canada C-Reactive Protein Testing Market Overview
  • 25.2. Canada C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America C-Reactive Protein Testing Market

  • 26.1. South America C-Reactive Protein Testing Market Overview
  • 26.2. South America C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil C-Reactive Protein Testing Market

  • 27.1. Brazil C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East C-Reactive Protein Testing Market

  • 28.1. Middle East C-Reactive Protein Testing Market Overview
  • 28.2. Middle East C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa C-Reactive Protein Testing Market

  • 29.1. Africa C-Reactive Protein Testing Market Overview
  • 29.2. Africa C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. C-Reactive Protein Testing Market Competitive Landscape And Company Profiles

  • 30.1. C-Reactive Protein Testing Market Competitive Landscape
  • 30.2. C-Reactive Protein Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

31. C-Reactive Protein Testing Market Other Major And Innovative Companies

  • 31.1. Abbott Laboratories
  • 31.2. Aidian Oy
  • 31.3. Boditech Med Inc.
  • 31.4. Horiba Ltd.
  • 31.5. Laboratory Corporation
  • 31.6. Merck KGAA
  • 31.7. Randox Laboratories Limited
  • 31.8. Getein Biotech Inc.
  • 31.9. Bio-Rad Laboratories Inc.
  • 31.10. DiaSorin S.p.A.
  • 31.11. Eurofins Scientific SE
  • 31.12. Inova Diagnostics Inc.
  • 31.13. Luminex Corporation
  • 31.14. Sekisui Diagnostics LLC
  • 31.15. Sysmex Corporation

32. Global C-Reactive Protein Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The C-Reactive Protein Testing Market

34. Recent Developments In The C-Reactive Protein Testing Market

35. C-Reactive Protein Testing Market High Potential Countries, Segments and Strategies

  • 35.1 C-Reactive Protein Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 C-Reactive Protein Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 C-Reactive Protein Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer